1 (877) 622-2022

Payers have a keen understanding that the diagnoses and treatment for Obstructive Sleep Apnea is driving up healthcare costs. OSA is not an uncommon problem - it is estimated that over 40 million Americans have this sleep disorder. Additionally, research (2008, CDC) indicates that there is an overwhelming undiagnosed population - over 70%!

With a large prevalence of undiagnosed OSA and the associated comorbidities, such as heart disease, diabetes and hypertension, payers are committed to finding ways to offer their members easy access and cost effective solutions to provide diagnoses and treatment of OSA.

This is where Night Hawk Sleep Systems Inc, comes in. Not only do we provide national coverage for less costly in-home sleep studies (HST), we also assist with the management and utilization of PAP therapy. Night Hawk can help payers meet their provider and member needs by offering a less disruptive and cost-effective monitoring service.

Years of Experience

The leadership of Robert Rudowski, Member of American Academy of Sleep Medicine, and CEO of Night Hawk has more than 15 years experience with in-home testing.

Innovative

Our secure, web-based technology platform allows for remote home testing, leading to accurate diagnosis as well as the ability to manage the CPAP device all within a single web portal. The process is all automatic and only requires a onetime entering of patient data and policy information. When you use Night Hawk, the manual process of sorting, uploading and translating CPAP device data into different systems is eliminated.

Payer Advantage

Night Hawk offers the Payer improved utilization, lower diagnoses costs with an option for ongoing monitoring of patient treatment.
Contact Us Now